Drugs / Group C
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT02003313 Comparator | Nov 2013 → May 2015 | meningitis | Beijing Minhai Biotechnology Co., Ltd | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Group C | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02003313 ↗ |
| Modality | Vaccine | “Group A, C, Y and W135 Meningococcal Polysaccharide Vaccine” NCT02003313 ↗ |